PDGFRA mutations in exons 12, 14, and 18 occur in approximately 15% of all patients with GIST.5 There is also a proportion of GIST (10%-15%) that lacks mutations in KIT and PDGFRA (the so-called wild-type [WT] tumors). Here, PDGFRA is linked to gastrointestinal stromal tumor.